Fate of cationic liposomes and their complex with oligonucleotide in vivo.
about
Liposomes as nanomedical devicesBorrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokinesLipoplexes and tumours. A review.Next generation delivery system for proteins and genes of therapeutic purpose: why and how?In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.Delivery of novel macromolecular drugs against HIV-1.Vehicles for oligonucleotide delivery to tumours.Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.Biodistribution and blood clearance of plasmid DNA administered in arginine peptide complexes.Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesCell-specific targeting of lipid-based carriers for ODN and DNA.Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy.Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.New methodologies to characterize the effectiveness of the gene transfer mediated by DNA-chitosan nanoparticles.Gene delivery to the rat liver using cationic lipid emulsion/DNA complex: comparison between intra-arterial, intraportal and intravenous administration.Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.Lipid-based nanotherapeutics for siRNA deliveryApplication of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery.Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.An epidermal growth factor motif from Del1 protein increases the efficiency of in vivo gene transfer with a non-viral vector.Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging.Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia.Cationic vesicles from novel bolaamphiphilic compounds.Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice.Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes.Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats.Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles.The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes.Overexpression of GRF encapsulated in PLGA microspheres in animal skeletal muscle induces body weight gain.Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
P2860
Q28088315-EFD45C64-A8E4-4C2B-8E48-03FD6171E7E7Q33603081-1DDC6454-4EE8-41C7-B88F-A2CB17FB5765Q33723073-283928B2-10D7-4BE9-ACEA-543ADDE7CF9BQ34003800-CBEB9BAB-F0C7-4BE9-A1C8-080E0E353918Q34273340-A3D1D386-22E6-46B1-B468-09DECF3FEBDFQ34452681-3AC373C6-7AE2-4604-8B3A-38F86F155FE1Q34518719-A985221C-0084-4BCE-9CD5-981E288E246BQ34634385-78A351F9-9DE8-4616-941F-6C092CB06D3DQ34640040-E13DB905-6FEF-4765-968E-1276557757D8Q35206023-736B7C43-59C7-430C-A044-1F2F908E7A32Q35605267-133BBCD2-B9B3-4CBC-BABB-962CB4719A43Q36272601-03C1B238-5E1F-4B5D-9082-120D10AC14B9Q36515486-38DF089E-C3C0-429B-9F76-3F2DC1BDFD69Q36606368-E8431045-7A6C-483C-B5AE-D634F6DBFBD6Q36968187-427B7264-67A1-416B-B5F1-A55A5CE576E1Q37085394-06DB432A-3FF9-4EC6-ABB6-1D4EB494B9FCQ37270210-3D29DF85-2C98-438A-8C2A-AA67F4772CA3Q37380192-892E9823-037F-4F06-AAD0-5210AA4DF10EQ37670986-6DB1BCC2-053B-4239-8756-AFE4DBDC3EFEQ37689857-7AB39C37-A8FE-4E0A-8395-159A38B86F9EQ38205757-D3D20F2F-2993-49C9-BB45-F8B385CE3A8EQ38315868-A1EE7441-29B8-4611-BBEE-86D72B5D53A5Q38750076-B8EAB61D-E7D1-4F8D-AFF8-6966BD2D8CA7Q39085570-E3B61696-9163-42E0-BA1C-AAA22BCD3747Q39196485-02C2A2FC-CC9D-40EC-989A-077138ECC260Q39316762-CACE6EA6-E2AD-42A2-A8BD-8F43503CE2E4Q39911952-4939A70D-50FA-4955-93B2-4CFE315BA7BBQ39913293-88E1AA84-5BE3-4BA9-8B5F-89DA794B6148Q41014533-6351E581-BF31-4BC2-BA27-27AC65E0C0FEQ41531194-5EACF120-A9DA-4490-989F-38F356CBA5FCQ43256749-F363AA72-B440-4488-B5DF-A569CA6A9AF4Q43437172-92A7A783-F8A0-436C-B606-B3F3F0E60D33Q43741864-CB26522E-28B2-4072-88FE-A511E71C109EQ43844857-041F0168-9E81-461F-A9B0-6081270DCBA3Q45055085-DC32DBC8-6222-4411-9D68-816C1C1D7AC6Q45862556-FB468B4E-71D6-4D01-9B4B-6A5D81DF6F48Q45888099-756E118F-324C-4E32-B158-02D0119B2F53Q47280759-FC54466E-B733-4DD7-A1AD-B1B5DDBF6448Q47900642-6BDB47FE-87A5-479F-A152-984972636650Q48029068-5FF75917-CFA3-4AA6-BAC9-C87E4ED9CFBE
P2860
Fate of cationic liposomes and their complex with oligonucleotide in vivo.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Fate of cationic liposomes and their complex with oligonucleotide in vivo.
@en
type
label
Fate of cationic liposomes and their complex with oligonucleotide in vivo.
@en
prefLabel
Fate of cationic liposomes and their complex with oligonucleotide in vivo.
@en
P2093
P1476
Fate of cationic liposomes and their complex with oligonucleotide in vivo.
@en
P2093
C L Farrell
D C Litzinger
S A Kaufman
P304
P356
10.1016/0005-2736(95)00268-5
P407
P577
1996-06-01T00:00:00Z